The FDA wrapped up 2024 with 50 new drug approvals, clearing a wave of long-awaited treatments. Meanwhile, Transcarent will ...
The US Food and Drug Administration approved 50 new molecular entities in 2024 —just five fewer than it did in 2023. Last ...
People with Medicare Part D plans shoulder a share of the cost of their prescription drugs. Under the standard Part D benefit ...
Findings show the impact of drug companies’ relentless price increases, underscoring the importance of the changes included in the historic 2022 drug law ...
Millions of Medicare enrollees are likely to see relief in 2025 when a $2,000 cap on out-of-pocket prescription drug-spending ...
Bayer AG reported positive results for elinzanetant in women with or at high risk of a type of breast cancer, broadening the ...
Washington researchers and care providers are struggling to keep up with new chemicals in the region’s illicit drug supply.
Britain's Terry Smith made public for the first time on Thursday why his fund dumped its Diageo stake last year, citing ...
Senate Bill 1553 classifies the use of illicit drugs on board public transit vehicles as a Class A misdemeanor, punishable by ...
A key cost-saving provision of the Inflation Reduction Act (IRA) goes into effect in the new year, limiting annual ...